| Particulars (Rupees in Crores.) | Dec-2024 | Dec-2023 |
|---|---|---|
Gross Sales | 284.04 | 112.08 |
Excise Duty | 0 | 0 |
Net Sales | 284.04 | 112.08 |
Other Operating Income | 0 | 0 |
Other Income | 7.49 | 0.86 |
Total Income | 291.53 | 112.94 |
Total Expenditure | 213.78 | 92.87 |
PBIDT | 77.75 | 20.07 |
Interest | 16.25 | 6.42 |
PBDT | 61.5 | 13.65 |
Depreciation | 11.61 | 6.31 |
Minority Interest Before NP | 0 | 0 |
Tax | 8.83 | 2.04 |
Deferred Tax | 0.69 | -13.23 |
Reported Profit After Tax | 40.37 | 18.53 |
Minority Interest After NP | -0.36 | 3.01 |
Net Profit after Minority Interest | 40.73 | 15.52 |
Extra-ordinary Items | 0 | 0 |
Adjusted Profit After Extra-ordinary item | 40.73 | 15.52 |
EPS (Unit Curr.) | 12.14 | 8.68 |
Book Value (Unit Curr.) | 0 | 0 |
Dividend (%) | 0 | 0 |
Equity | 46.05 | 29.95 |
Public Shareholding (Number) | 0 | 0 |
Public Shareholding (%) | 0 | 0 |
Pledged/Encumbered - No. of Shares | 0 | 0 |
Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 |
Pledged/Encumbered - % in Total Equity | 0 | 0 |
Non Encumbered - No. of Shares | 0 | 0 |
Non Encumbered - % in Total Promoters Holding | 0 | 0 |
Non Encumbered - % in Total Equity | 0 | 0 |
PBIDTM(%) | 27.37 | 17.9 |
PBDTM(%) | 21.65 | 12.17 |
PATM(%) | 14.21 | 16.53 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
